Phase i/ii study of fluosol®-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck

International Journal of Radiation Oncology, Biology, Physics

Volumn 16, Issue 6, 1989, Pages 1587-1593

  Lustig, Robert ^a   McIntosh Lowe, Norma ^b   Rose, Christopher ^c   Haas, Judith ^d   Krasnow, Steven ^e   Spaulding, Monica ^f   Prosnitz, Leonard ^g  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^b Grifols SA   (United States)

^c Section of Vascular Surgery   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Head and neck cancer; Oxygen; Perfluorochemicals

Indexed keywords

FLUOSOL DA; OXYGEN;

ADULT; AGED; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOTHERAPY;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; DRUG EVALUATION; FEMALE; FLUOROCARBONS; HEAD AND NECK NEOPLASMS; HUMAN; MALE; OXYGEN INHALATION THERAPY; PROGNOSIS;

EID: 0024380933     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(89)90967-X     Document Type: Article

References (18)

1. The Amsterdam fast neutron project, a final report
2. Radiation therapy in hyperbaric oxygen for head and neck cancer at Royal Adelaide Hospital 1964–1980
3. Fast neutron therapy for squamous cell carcinoma of the head and neck: results of a randomized trial
4. Failure of misonidazole-sensitized radiotherapy to impact upon outcome among Stage III–IV squamous cell cancers of the head and neck
5. Oxygen tension in human tumors: In vivo mapping using CT guided probes
6. Substitutes for blood and its components
7. Ninth Annual del Regato Lecture; optimal multidisciplinary management of head and neck cancer
8. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity pharynx larynx and sinuses using radiation therapy as the only planned modality (preliminary report) by the Radiation Therapy Oncology Group
9. Radiation Therapy Oncology Group studies in head and neck cancer
10. Clinical studies of perfluorochemical blood substitutes: safety of Fluosol®-DA in normal human volunteers
11. Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor
12. Reaction of tumors and normal tissue in mice to irradiation in the presence and absence of a perfluorochemical emulsion
13. 2 and radiosensitivity of tumors by Fluosol®-DA (20%) and carbogen
14. Oxygen carrying perfluorochemical emulsions as an adjuvant to radiation therapy in mice
15. Perfluorochemical emulsions can enhance the effect of radiation in mouse tumors
16. The histological structure of some human lung cancers and the possible implications for radiation therapy
17. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen transport fluid, Fluosol®-DA
18. Activation of plasma complement by perfluorocarbon artificial blood: Probable of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis